These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17126204)
41. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients. Kassim I; Dirkx ML; Heijmen BJ Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745 [TBL] [Abstract][Full Text] [Related]
42. [Complications following external radiotherapy of prostate cancer. Case reports and overview of the literature]. Schmiedt E; Schmeller N; Mayer P Urologe A; 1984 May; 23(3):149-52. PubMed ID: 6539989 [TBL] [Abstract][Full Text] [Related]
43. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064 [TBL] [Abstract][Full Text] [Related]
44. Second cancers in children treated with modern radiotherapy techniques. Schneider U; Lomax A; Timmermann B Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783 [TBL] [Abstract][Full Text] [Related]
45. [Three-dimensional conformal radiation therapy for prostate cancer in Hamamatsu Medical Center]. Kanda T; Nakagomi K; Goto S; Iijima M Hinyokika Kiyo; 2007 Jan; 53(1):9-12. PubMed ID: 17310762 [TBL] [Abstract][Full Text] [Related]
47. RapidArc volumetric modulated therapy planning for prostate cancer patients. Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157 [TBL] [Abstract][Full Text] [Related]
48. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial. van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862 [TBL] [Abstract][Full Text] [Related]
49. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? Klein EA; Ciezki J; Kupelian PA; Mahadevan A Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801 [TBL] [Abstract][Full Text] [Related]
50. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Vargas C; Mahajan C; Fryer A; Indelicato D; Henderson RH; McKenzie C; Horne D; Chellini A; Lawlor P; Li Z; Oliver K; Keole S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1110-6. PubMed ID: 17967305 [TBL] [Abstract][Full Text] [Related]
51. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572 [TBL] [Abstract][Full Text] [Related]
52. When should the seminal vesicles be included in the target volume in prostate radiotherapy? Bayman NA; Wylie JP Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647 [TBL] [Abstract][Full Text] [Related]
53. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142 [TBL] [Abstract][Full Text] [Related]
54. Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Mayahara H; Murakami M; Kagawa K; Kawaguchi A; Oda Y; Miyawaki D; Sasaki R; Sugimura K; Hishikawa Y Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):434-43. PubMed ID: 17482768 [TBL] [Abstract][Full Text] [Related]
55. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer. Phan TP; Syed AM; Puthawala A; Sharma A; Khan F J Urol; 2007 Jan; 177(1):123-7; discussion 127. PubMed ID: 17162020 [TBL] [Abstract][Full Text] [Related]
56. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. Schneider U; Lomax A; Besserer J; Pemler P; Lombriser N; Kaser-Hotz B Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):892-7. PubMed ID: 17459608 [TBL] [Abstract][Full Text] [Related]
57. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. Pommier P; Chabaud S; Lagrange JL; Richaud P; Lesaunier F; Le Prise E; Wagner JP; Hay MH; Beckendorf V; Suchaud JP; Pabot du Chatelard PM; Bernier V; Voirin N; Perol D; Carrie C J Clin Oncol; 2007 Dec; 25(34):5366-73. PubMed ID: 18048817 [TBL] [Abstract][Full Text] [Related]
58. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both? Roach M Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004 [TBL] [Abstract][Full Text] [Related]
59. Are we making progress with argon plasma coagulation in chronic radiation proctopathy? Kwon RS; Carr-Locke DL J Gastroenterol Hepatol; 2005 Feb; 20(2):171-2. PubMed ID: 15683416 [No Abstract] [Full Text] [Related]
60. Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading method. Chi KD; Ehrenpreis ED; Jani AB J Clin Gastroenterol; 2005 Jan; 39(1):42-6. PubMed ID: 15599209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]